Bone Effects of Exemestane vs. Tamoxifen within the German TEAM trial: Results of a Prospective Randomized Bone Sub-Study. 30. Mai 2008 Hadji, P., Ziller, M., Kieback, D., Dornoff, W., Tessen, H., Kuck, J., Hasenburg, A., 2008. Cancer Res 69(2 Supplement), 1143. doi:10.1158/0008-5472.SABCS-1143 Abstract Colon Registry: Influence of comorbidity on the choice of chemotherapeutic treatment. A joint project of the AIO and the AKS. Freier, W., Arnold, D., Otremba, B., Marschner, N., 2008. Onkologie 31 (suppl 4)(P301), 109. doi:10.1159/000161574 Abstract… Weiterlesen Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausalearly breast cancer. Jones, S.E., Seynaeve, C., Hasenburg, A., Rea, D., Vannetzel, J.M., Paridaens, R., Markopoulos, C., Hozumi, Y., Putter, H., Hille, E., Kieback, D.G., Asmar, L., Smeets,… Weiterlesen